Chronic cough, defined as a cough lasting more than eight weeks, presents a prevalent yet complex issue in clinical practice. Despite its seeming simplicity, its multifaceted nature poses a challenge to healthcare professionals. This article seeks to shed light on this often mystifying condition and provide a comprehensive approach to its management.
Chronic cough can be attributed to a plethora of causes, including but not limited to postnasal drip syndrome, gastroesophageal reflux disease (GERD), and asthma. It is crucial to conduct a thorough patient history and physical examination to identify potential causes. Additional diagnostic tests may be necessary to confirm the diagnosis.
Treatment should be individualized based on the identified cause. For instance, GERD-related coughs may require proton pump inhibitors, while coughs due to asthma might need inhaled corticosteroids. It is essential to monitor patients closely and adjust the treatment plan as necessary.
Refractory chronic cough, or cough that remains unresponsive to treatment, requires further evaluation. This could include high-resolution computed tomography, bronchoscopy, or referral to a specialist. Neuromodulatory therapies can be considered in cases of refractory chronic cough.
Patients must understand their condition and the importance of adhering to the treatment plan. Educating patients about potential triggers and how to avoid them can also be beneficial. Regular follow-up appointments should be scheduled to monitor progress and make necessary adjustments to the treatment plan.
Chronic cough, while common, is a complex condition that requires a comprehensive and individualized approach. By understanding the underlying causes, implementing tailored treatment plans, addressing refractory cases, and emphasizing patient education, healthcare professionals can effectively manage chronic cough in clinical practice.
1.
MRI can save rectal cancer patients from surgery, study suggests
2.
When Healthcare Chatbots Fall Short of Human Connection
3.
Multidrug Regimen Could Change Treatment Landscape for Relapsed/Refractory DLBCL
4.
Antibiotic Use in Hospice Linked to Higher Mortality Risk
5.
Two Survival Wins in NSCLC With Bispecific Seeking Worldwide Status
1.
Multiple Primary Lung Cancer: Multidisciplinary Advances in Diagnosis and Care
2.
Genetic Screening: A Game Changer in Cancer Prevention
3.
All You Need to Know About Mesna: The Ultimate Guide
4.
Unveiling the Hidden Causes of Anemia: A Comprehensive Look at a Common Condition
5.
Targeting BRAF V600E in mCRC: FOLFOX, Cetuximab & Encorafenib Strategies
1.
International Conference on Oncology, Cardiology and Critical Care Policy
2.
International Conference on Innovations in Critical Care for Oncology and Cardiology
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Cancer Nursing and Hematology Support
1.
Innovations in Hematology
2.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- Further Discussion on A New Perspective
3.
Should We Use DARA Up Front As First-Line Therapy in MM? - Part II
4.
A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC
5.
Blood Clotting Disorders Explained
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation